Alex Starr
Impact in
- Molecular Medicine top 2%
- Curcumin's Biomedical Applications
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
- Oncology 16
- HER2/EGFR in Cancer Research 10
- Peptidase Inhibition and Analysis 4
- Cancer Treatment and Pharmacology 3
-
- Glycosylation and Glycoproteins Research 4
- Co-authors
- Rami Ben‐Yosef (12 shared papers)Akiva Vexler (12 shared papers)Shahar Lev‐Ari (8 shared papers)Nadir Arber (6 shared papers)Joel Greif (3 shared papers)Dan Aderka (2 shared papers)Eyal Sagiv (1 shared paper)Timothy C. Wang (1 shared paper)
- Journals
- Targeted Oncology (2 papers)The International Journal of Biological Markers (2 papers)Oncogene (2 papers)Cancer Research (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Alex Starr
25 papers receiving 917 citations
Peers
Comparison fields: 5 of 88
- Molecular Medicine 229
- Oncology 350
- Molecular Biology 532
- Cancer Research 111
- Transplantation 15
Countries citing papers authored by Alex Starr
This map shows the geographic impact of Alex Starr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Starr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Starr more than expected).
Fields of papers citing papers by Alex Starr
This network shows the impact of papers produced by Alex Starr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Starr. The network helps show where Alex Starr may publish in the future.
Co-authors
The 25 scholars most cited alongside Alex Starr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 134 | |
| 2 | Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity. | 2007 | 120 |
| 3 | 2007 | 119 | |
| 4 | 2007 | 95 | |
| 5 | 2005 | 65 | |
| 6 | 2009 | 54 | |
| 7 | 2006 | 53 | |
| 8 | 2010 | 50 | |
| 9 | 2009 | 40 | |
| 10 | 2014 | 38 | |
| 11 | 2011 | 25 | |
| 12 | The lack of predictive value of preoperative psychologic distress for postoperative medical outcome in heart transplant recipients. | 1992 | 24 |
| 13 | 2012 | 21 | |
| 14 | 2010 | 18 | |
| 15 | 2011 | 16 | |
| 16 | 2012 | 15 | |
| 17 | 2007 | 14 | |
| 18 | OKT3-induced hypotension in heart allograft recipients treated for steroid-resistant rejection. | 1989 | 10 |
| 19 | 2005 | 7 | |
| 20 | 2011 | 6 |
About Alex Starr
Alex Starr is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 25 papers that have together received 936 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (10 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Glycosylation and Glycoproteins Research (4 papers), Peptidase Inhibition and Analysis (4 papers), Cancer Treatment and Pharmacology (3 papers), Synthesis and biological activity (3 papers), Inflammatory mediators and NSAID effects (3 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Molecular Medicine (229 citations), Oncology (350 citations), Molecular Biology (532 citations), Cancer Research (111 citations) and Transplantation (15 citations). Alex Starr has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Rami Ben‐Yosef, Akiva Vexler, Shahar Lev‐Ari, Nadir Arber, Joel Greif, Dan Aderka, Eyal Sagiv, Timothy C. Wang, Uri Rozovski and Peter Altevogt. Their work appears in journals such as Targeted Oncology, The International Journal of Biological Markers, Oncogene, Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.